What are the symptoms of an insulinoma (insulin-producing tumor)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Insulinoma symptoms primarily result from hypoglycemia due to excessive insulin secretion by this pancreatic tumor, and the classic presentation includes Whipple's triad: hypoglycemic symptoms, low blood glucose levels, and relief of symptoms after glucose administration. The symptoms of insulinoma can be divided into two main categories: neuroglycopenic and autonomic symptoms. Neuroglycopenic symptoms occur due to the lack of glucose in the brain and include confusion, unusual behavior, visual disturbances, weakness, fatigue, seizures, and even loss of consciousness or coma 1. Autonomic symptoms, on the other hand, occur as the body responds to low blood sugar, including sweating, trembling, heart palpitations, anxiety, and hunger.

  • These symptoms typically appear during fasting or exercise when blood glucose naturally decreases, but can sometimes occur after meals.
  • A distinctive feature of insulinoma is weight gain, as patients may eat frequently to avoid hypoglycemic episodes.
  • Symptoms can be intermittent and vague, often leading to misdiagnosis as psychiatric, neurological, or cardiac disorders. The severity and frequency of symptoms depend on insulin secretion patterns, with some patients experiencing mild occasional symptoms while others have frequent severe episodes requiring emergency care 1. Morning headaches and nightmares may occur due to nocturnal hypoglycemia. Prompt evaluation is essential as prolonged or severe hypoglycemic episodes can cause permanent neurological damage.
  • It is also important to note that insulinomas can be localized by injecting calcium into selective pancreatic arteries and measuring the insulin levels in the right or left hepatic vein (Imamura-Doppman procedure) 1.
  • Serum insulin, proinsulin, and C peptide should be tested to confirm the diagnosis of insulinoma, and a 48- to 72-hour observed or inpatient observed fast may also be helpful in uncertain cases 1.

From the Research

Symptoms of Insulinoma

The symptoms of insulinoma are primarily caused by hypoglycemia, which leads to neuroglycopenia and catecholamine response 2. Some of the key symptoms and characteristics include:

  • Hypoglycemia with blood glucose levels less than 40 mg/dl (less than 2.2 mmol/l) 2
  • Concomitant insulin levels greater than or equal to 6 IU/ml (greater than or equal to 43 pmol/l) 2
  • Concomitant C-peptide levels greater than or equal to 0.2 pmol/l 2
  • Neuroglycopenic and hypoglycemic symptoms, such as confusion, shakiness, and loss of consciousness 3
  • Catecholamine response, which can cause symptoms such as palpitations, sweating, and anxiety 2

Diagnosis and Management

The diagnosis of insulinoma is typically confirmed by a supervised fast, and early detection is important 4. The management of insulinoma usually involves surgical excision of the tumor, which can be curative in most cases 2, 4. In some cases, medical therapy with somatostatin analogues, such as octreotide or lanreotide, may be used to control hypoglycemia 5, 6.

Complications and Treatment

In some cases, insulinoma can be associated with other conditions, such as multiple endocrine neoplasia type-1 syndrome 4 or pheochromocytoma 6. The treatment of insulinoma may involve a multidisciplinary approach, including surgery, medical therapy, and lifestyle modifications 2, 4, 6, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulinoma.

Neuroendocrinology, 2004

Research

Insulinoma.

The Surgical clinics of North America, 2009

Research

Insulinoma: pathophysiology, localization and management.

Future oncology (London, England), 2010

Research

Effective therapy of insulinoma by using long-acting somatostatin analogue. A case report and literature review.

Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.